Takeda receives positive chmp opinion for hyqvia® as maintenance therapy in patients with chronic inflammatory demyelinating polyneuropathy (cidp)

Osaka, japan & cambridge, mass.--(business wire)--the chmp has recommended the approval of takeda's hyqvia in patients with cidp as maintenance therapy after stabilization with ivig.
TAK Ratings Summary
TAK Quant Ranking